Status:
UNKNOWN
Comparison of the Effectiveness of Two Different Antibiotic Regimens of the Treatment of Pregnant Women With Preterm Rupture of Membranes
Lead Sponsor:
Hacettepe University
Conditions:
Preterm Membrane Rupture
Neonatal Sepsis
Eligibility:
All Genders
1-15 years
Brief Summary
There is no consensus around the world on the treatment of preterm rupture of membranes, which is one of the important causes of early neonatal sepsis and one of the common causes of prematurity. Diff...
Eligibility Criteria
Inclusion
- Having received azithromycin-ampicillin or sulbactam-ampicillin treatment during antenatal period with the diagnosis of preterm rupture of membranes that started before 34 weeks.
Exclusion
- Having a disease detected in the perinatal or neonatal period (such as hydrops, congenital anomalies)
- Having a history of iatrogenic preterm birth
- Lethal or chromosomal anomaly
- Being diagnosed with perinatal hypoxia, hypoxic ischemic encephalopathy
Key Trial Info
Start Date :
September 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2021
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT04528251
Start Date
September 1 2020
End Date
August 1 2021
Last Update
August 27 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hacettepe University
Ankara, Turkey (Türkiye), 06230